Matthew B. Klein, CHIEF EXECUTIVE OFFICER at PTC THERAPEUTICS, INC. (PTCT), sold 6,856 shares at $79.07 ($542K) on 2025-12-02, disclosed to the SEC on 2025-12-03.
Scheduled sale ($542k) by CHIEF EXECUTIVE OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $79.07 | 3,428 | $271K | 50.0% |
| 2 | $79.07 | 3,428 | $271K | 50.0% |
| Total | $79.07 avg | 6,856 | $542K | 100% |
| Filing → |
| PTCT | SELL | 2026-05-15 | $917K | — | Filing → |
| PTCT | SELL | 2026-04-23 | $202K | — | Filing → |
| PTCT | SELL | 2026-03-13 | $171K | — | Filing → |